Journal
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 17, Issue 1, Pages 4-13Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2020.1771986
Keywords
Immunotherapy; melanoma; uveal melanoma; conjunctival melanoma
Categories
Ask authors/readers for more resources
Immunotherapy shows varying efficacy in different types of melanoma due to their different biological features. Further research is needed to explore the effectiveness of immune checkpoint inhibitors in various types of melanoma.
Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available